Harte Hanks, Inc. HHS
4.60
(0.05)
(1.08%)
as of 25 Sep
- Market cap
- $34.6M
- P/E
- 0.0×
Follow HHS
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.16 | 0.14 | 0.11 | 0.10 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
8.61 | 30.19 | (29.28) | (7.75) | |
P/B ratio |
1.38 | 1.08 | 0.84 | 1.05 | |
Price to Tangible BV |
1.44 | 1.12 | 0.86 | 1.09 | |
EV/Sales |
0.24 | 0.22 | 0.20 | 0.18 | |
EV/EBITDA |
11.19 | 7.34 | 7.54 | 0.00 | |
EV/Operating CF |
25.43 | (20.56) | (20.98) | 21.32 | |
EV/FCF |
(103.36) | (7.94) | (6.97) | (18.93) | |
Quick Ratio |
1.11 | 1.34 | 1.26 | 1.16 | |
Current Ratio |
1.48 | 1.54 | 1.49 | 1.30 | |
Net Debt/EBITDA |
(3.77) | (5.54) | (14.45) | 0.65 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 3.41% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.20 | |
Asset Turnover |
1.66 | 1.65 | 1.63 | 1.69 | |
Operating CF/Net income |
(1.40) | 0.33 | 0.92 | 0.41 | |
Capex/Depreciation |
(0.83) | (1.26) | (0.32) | 0.04 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.03% | 14.25% | 15.14% | 23.13% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.38% | (0.16%) | 0.59% | 0.58% | |
Graham Net Nets |
(0.88) | (1.12) | (1.46) | (1.70) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(19.95%) | (3.65%) | (6.17%) | (35.19%) | |
Free Cash Flow Yield |
(1.41%) | (20.18%) | (26.68%) | (9.02%) | |
Revenue per Share |
5.33 | 5.39 | 5.02 | 5.11 | |
Operating CF per Share |
0.43 | 0.10 | (0.08) | (0.28) | |
Capex per Share |
(0.14) | (0.19) | (0.05) | 0.01 | |
Free Cash Flow per Share |
0.30 | (0.09) | (0.12) | (0.27) | |
Cash per Share |
0.88 | 0.76 | 0.61 | 0.70 | |
Shareholders Equity per Share |
2.68 | 2.78 | 2.71 | 2.07 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.68 | 2.78 | 2.71 | 2.07 | |
Free Cash Flow |
2.19 | (0.68) | (0.92) | (2.03) | |
Working Capital |
15.70 | 16.15 | 15.06 | 10.49 | |
Capital Expenditures |
(1.01) | (1.42) | (0.35) | 0.04 | |
Net Current Asset Value |
(24.13) | (24.98) | (24.52) | (27.35) | |
EV/EBIT |
0.00 | 92.40 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.01 | 0.00 | |
Net Profit Margin |
(5.78%) | 5.52% | (1.69%) | (13.17%) | |
Price to Operating Income |
0.00 | 57.65 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
31.74 | 33.27 | 31.88 | 34.91 | |
Average Payables |
19.49 | 13.26 | 16.53 | 15.92 | |
Average Assets |
100.42 | 96.80 | 95.50 | 91.54 | |
Average Common Equity |
20.46 | 21.11 | 20.76 | 18.80 |
Columns are period end dates